CC Pharma Nordic ApS: Financial statements 2019
CVR: 39461528
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CC Pharma Nordic ApS (CVR 39461528) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -194,048 and a net result of DKK -830,910. Equity in the 2019 report amounted to DKK -1,100,287. The company had 1 employee in the financial year.
- Gross Profit
- DKK -194,048
- Profit/Loss
- DKK -830,910
- Equity
- DKK -1,100,287
- Total Assets
- DKK 1,036,202
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CC Pharma Nordic ApS has published its interim report for the period April 3, 2018 – December 31, 2018.
As of March 20, 2019, Bo Tandrup has joined the board of directors of CC Pharma Nordic ApS.
As of March 20, 2019, Klaus Herbert Becker is registered as chairman of CC Pharma Nordic ApS.
As of March 19, 2019, Klaus Herbert Becker has left the board of directors of CC Pharma Nordic ApS.
As of March 19, 2019, Bo Tandrup has stepped down as chairman of CC Pharma Nordic ApS.
About CC Pharma Nordic ApS
CC Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 7 January 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Astea Pharma ApS. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK -215,055 and a net result of DKK -807,857 compared with DKK -2,730,659 the year before. Equity in the 2023 report amounted to DKK -7,707,025.